Literature DB >> 19752532

Diverse effects of ischemic pretreatments on the long-term renal damage induced by ischemia-reperfusion.

Suhua Jiang1, Yue Chen, Jianzhou Zou, Xunhui Xu, Xiaoli Zhang, Chunfeng Liu, Yi Fang, Xiaoqiang Ding.   

Abstract

BACKGROUND/AIMS: The role of ischemic pretreatment in long-term changes after renal ischemia-reperfusion (I/R) injury remains unknown. In this study, we mainly aimed to investigate the effect of ischemic pretreatments with different durations on the development of tubulointerstitial fibrosis and functional impairment following acute renal I/R.
METHODS: We established a rat model of renal warm I/R, clamping both pedicles for 40 min followed by reperfusion; the experiment was followed up for 10 weeks. Prior ischemia (10, 20, 30 min) was induced 8 days before the 40-min ischemia. To assess tissue fibrosis, we performed morphometric analysis, Masson's trichrome and Sirius red staining. We also analyzed the expression of alpha-smooth muscle actin (alpha-SMA), transforming growth factor-beta(1) (TGF-beta(1)) and phospho-Smad2.
RESULTS: Patchy tubulointerstitial fibrosis was found 5 and 10 weeks later in rats subjected to I/R alone or pretreated with 10-min ischemia. Tubulointerstitial fibrosis deteriorated further and renal dysfunction occurred in rats pretreated with 30-min ischemia accompanied by increased expression of alpha-SMA, TGF-beta(1), and phospho-Smad2 at 5 weeks. In contrast, the above abnormalities were significantly attenuated in rats pretreated with 20-min ischemia.
CONCLUSION: Severe I/R injury may cause tubulointerstitial fibrosis in the long term, and different ischemic pretreatments have diverse effects on renal fibrosis. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752532     DOI: 10.1159/000239574

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  8 in total

Review 1.  miR-21 in ischemia/reperfusion injury: a double-edged sword?

Authors:  Xialian Xu; Alison J Kriegel; Xiaoyan Jiao; Hong Liu; Xiaowen Bai; Jessica Olson; Mingyu Liang; Xiaoqiang Ding
Journal:  Physiol Genomics       Date:  2014-08-26       Impact factor: 3.107

2.  miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice.

Authors:  Ping Jia; Jie Teng; Jianzhou Zou; Yi Fang; Xiaoyan Zhang; Zeljko J Bosnjak; Mingyu Liang; Xiaoqiang Ding
Journal:  Anesthesiology       Date:  2013-09       Impact factor: 7.892

3.  miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation.

Authors:  Yi Fang; Xiaofang Yu; Yong Liu; Alison J Kriegel; Yanyan Heng; Xialian Xu; Mingyu Liang; Xiaoqiang Ding
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-06

Review 4.  Remote ischemic preconditioning as treatment for non-ischemic gastrointestinal disorders: beyond ischemia-reperfusion injury.

Authors:  Carlos Rodrigo Camara-Lemarroy
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

5.  Bone Marrow Derived Mesenchymal Stromal Cells Ameliorate Ischemia/Reperfusion Injury-Induced Acute Kidney Injury in Rats via Secreting Tumor Necrosis Factor-Inducible Gene 6 Protein.

Authors:  Yue Chen; Xiaochen Tang; Ping Li; Ying Zhou; Ting Xue; Jie Liu; Chen Yu
Journal:  Biomed Res Int       Date:  2019-03-11       Impact factor: 3.411

6.  Superagonistic CD28 protects against renal ischemia injury induced fibrosis through a regulatory T-cell expansion dependent mechanism.

Authors:  Yiran Liang; Ning Xue; Xiaoyan Wang; Xiaoqiang Ding; Yi Fang
Journal:  BMC Nephrol       Date:  2019-11-09       Impact factor: 2.388

7.  Intermittent exposure to xenon protects against gentamicin-induced nephrotoxicity.

Authors:  Ping Jia; Jie Teng; Jianzhou Zou; Yi Fang; Suhua Jiang; Xiaofang Yu; Alison J Kriegel; Mingyu Liang; Xiaoqiang Ding
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

8.  Role of miR‑21 on vascular endothelial cells in the protective effect of renal delayed ischemic preconditioning.

Authors:  Xialian Xu; Xiaoyan Jiao; Nana Song; Weili Luo; Mingyu Liang; Xiaoqiang Ding; Jie Teng
Journal:  Mol Med Rep       Date:  2017-06-28       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.